- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0020121

Brace Well Pharma Private Limited
About Brace Well Pharma Private Limited
Data last updated:
Brace Well Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2021PTC054960. Its GSTIN is 10AAJCB6425A1ZE (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Amresh Kumar Sinha and Navin Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 06 Omax City 2 Manglia Space, Indore, Madhya Pradesh, India – 453771.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.8 Lakh. For the same year it recorded a net profit of ₹50,548 (net margin 2%) and EBITDA of ₹62,565 (EBITDA margin 2.4%).
Brace Well Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0020121).
Company details
Recognitions & Rankings of Brace Well Pharma
Contact details
Brace Well Pharma Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 06 Omax City 2 Manglia Space, Indore, Madhya Pradesh, India – 453771
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Brace Well Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Brace Well Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brace Well Pharma Private Limited, buy the company report.
Financials of Brace Well Pharma Private Limited
FY 2025 filings availableBrace Well Pharma Private Limited reported revenue of ₹25.8 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹62,565 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹50,548 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.4% | |||
| Net Profit Margin | 2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Brace Well Pharma Private Limited, buy the company report.
Board of directors of Brace Well Pharma Private Limited
Brace Well Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amresh Kumar Sinha Also directs: Massive Laboratories Private Limited | Director | 18 Feb 2021 | 5 Years 9 Months | Current |
| Navin Kumar Also directs: Shovid Damodar Buildcon Private Limited | Director | 18 Feb 2021 | 5 Years 9 Months | Current |
| Puja Kumari | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Mukesh Kumar Jha | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Sabita Krishna | Director | 15 Feb 2023 | 3 Years 9 Months | Current |
Peer comparison
Brace Well Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Citrax Pharmaceutical Private Limited | ₹25.88 Lakh (FY 2025) | -19.0% | Rewari, Haryana, India | |||
| Saiprasad Chemical Specialities Private Limited | ₹25.87 Lakh (FY 2023) | 80.0% | Dombivli, Maharashtra, India | |||
| Siddhivinayak Medical Care India Private Limited | ₹25.84 Lakh (FY 2023) | 223.0% | Mumbai, Maharashtra, India | |||
| Crsons Healthcare Private Limited | ₹25.83 Lakh (FY 2023) | -65.0% | Pune, Maharashtra, India | |||
| Connectome Lifesciences (OPC) Private Limited | ₹25.82 Lakh (FY 2025) | 78.0% | Secunderabad, Telangana, India | |||
| Brace Well Pharma Private Limitedthis company | ₹25.8 Lakh (FY 2024) | ₹50,548 | 2% | Indore, Madhya Pradesh, India | ||
| Mehal Herbal Healthcare Private Limited | ₹25.8 Lakh (FY 2024) | -63.0% | Ambala, Haryana, India | |||
| Ailcure Pharmatech Private Limited | ₹25.79 Lakh (FY 2022) | 168.0% | Mumbai, Maharashtra, India | |||
| Filbs Nutra Private Limited | ₹25.79 Lakh (FY 2018) | -14.0% | Udaipur, Rajasthan, India | |||
| Polarstar Manufacturing Industries Private Limited | ₹25.77 Lakh (FY 2024) | 225.0% | Dewas, Madhya Pradesh, India | |||
| Usine Remedies Private Limited | ₹25.77 Lakh (FY 2024) | -17.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Brace Well Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brace Well Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brace Well Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Brace Well Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAJCB6425A1ZE | Bihar | Active | 26 Mar 2021 |
To see the full GST registrations and return filing status of Brace Well Pharma Private Limited, buy the company report.
Recent activity
Brace Well Pharma Private Limited has 6 board changes on record since 2021: 5 appointments and 1 cessation. The latest: Sabita Krishna was appointed as Director on 15 Feb 2023.
Frequently asked questions
Brace Well Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 February 2021 (5+ years old) and is registered under CIN U74999MP2021PTC054960.
Brace Well Pharma has 5 current directors:
- Amresh Kumar Sinha - Director
- Navin Kumar - Director
- Puja Kumari - Director
- Mukesh Kumar Jha - Director
- Sabita Krishna - Director
The latest financial statements of Brace Well Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Brace Well Pharma is 10AAJCB6425A1ZE, registered in Bihar.
The CIN (Corporate Identification Number) of Brace Well Pharma is U74999MP2021PTC054960. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brace Well Pharma was incorporated on 18 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Brace Well Pharma by revenue are Citrax Pharmaceutical Private Limited, Saiprasad Chemical Specialities Private Limited, Siddhivinayak Medical Care India Private Limited, Crsons Healthcare Private Limited, Connectome Lifesciences (OPC) Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sabita Krishna was appointed as Director on 15 Feb 2023. Mukesh Kumar Jha was appointed as Director on 20 Jul 2021. Puja Kumari was appointed as Director on 20 Jul 2021. Brace Well Pharma has 6 board changes on record in total.
Yes, Brace Well Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0020121).
The registered office of Brace Well Pharma is at Plot No 06 Omax City 2 Manglia Space, Indore, Madhya Pradesh, India – 453771.
Brace Well Pharma operates in the pharma industry, in the drug formulation and development segment.

